title: Subclinical rejection in renal transplants is associated with low serum mannose-binding lectin levels.
abstract: Surveillance biopsies have contributed to the understanding of the natural history of renal allograft lesions. Subclinical rejection, defined as the presence of histological lesions, indistinguishable from acute rejection in stable grafts, is associated with progression of interstitial fibrosis and tubular atrophy. The prevalence of subclinical rejection has decreased as more powerful immunosuppressive treatments have been introduced, suggesting that subclinical rejection represents the degree of control of the alloimmune response. However, non-immune factors such as donor age are also associated with the prevalence of subclinical rejection, suggesting that kidneys from older donors are more susceptible to insult and have a reduced capacity for tissue regeneration. Innate immunity has a crucial role in the modulation of the inflammatory response during infection and tissue damage. Mannose-binding lectin (MBL) is an innate immune protein, the polymorphisms of which are associated with infection, low-grade inflammation, diabetes, and cardiovascular disease. However, the relationship between MBL and disease is complex. For example, low MBL level is associated with higher risk for diabetes, whereas in patients with diabetes, high MBL level is associated with more severe renal damage. In renal transplant patients, low MBL levels are associated with an increased prevalence of infection and diabetes, whereas high MBL levels are associated with shortened graft survival. Although MBL is not clearly associated with prevalence of acute rejection, surveillance biopsy studies have shown that low MBL levels are associated with subclinical rejection in kidney and the heart, suggesting that MBL modulates the injury-repair process of the allograft.
authors.affiliation: Nephrology Department, Hospital Germans Trias i Pujol, Universitat Autónoma de Barcelona , Barcelona, Spain.
authors.forename: Meritxell
authors.initials: M
authors.lastname: Ibernon
authors.affiliation: Nephrology Department, Hospital Vall d'Hebron, Universitat Autónoma de Barcelona , Barcelona, Spain.
authors.forename: Francesc
authors.initials: F
authors.lastname: Moreso
authors.affiliation: Nephrology Department, Hospital Vall d'Hebron, Universitat Autónoma de Barcelona , Barcelona, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Serón
keywords: innate immunity; mannose-binding lectin; protocol biopsies; subclinical rejection